Category Archives: Strategy
By Casey McDonald | Published: December 12, 2014
Greetings to the Biotech/Pharma twittersphere! Starting this week, we’ll be compiling top tweets about the industry (semi-)regularly in this blog. Please help with suggestions on what you think should make the list. Tweet @PharmExecutive or email email@example.com.
By Tom Norton | Published: December 9, 2014
At first glance Obamacare developments for the American Rx industry in 2015 appear fairly benign. However, digging deeper suggests that each, in its own way, could cause various actions with potential for substantial uncertainty for the U.S. pharmaceutical industry next year. If your response to this profound observation was, “Really, what’s new?” — read on.
By Guest Blogger | Published: December 8, 2014
2014 marked the 80th anniversary of Laboratorios Bagó, a market leader in Argentina and also Latin America, with products in in 47 countries. In this interview with Pharmaboardroom.com, Juan Pablo Bagó, general director of pharma in Argentina for the Bagó group, discusses the state of R&D in Argentina, and explains why his group is planning for a 75 percent of turnover […]
By Casey McDonald | Published: December 4, 2014
PwC’s Health Research Institute (HRI) announced its top 10 health industry issues for 2015. The HRI’s top three emphasizes the possibilities of mobile device technologies for do-it-yourself (DIY) healthcare and the potential privacy concerns that could arise.
By Guest Blogger | Published: December 1, 2014
Peter Young examines the fast-moving growth drivers for the two segments and what their 2014 numbers mean for respective M&A and other strategies going forward. The pharmaceutical and biotechnology industries, like all industries, are facing industry-specific changes coupled with disruptive events in the external global environment. The industry business factors include the productivity and cost […]